Navigation Links
CoEase (1.2% sodium hyaluronate) viscoelastic solution

ProductsCoEase (1.2% sodium hyaluronate) viscoelastic solution
Company Advanced Medical Optics, Inc.
Item CoEase (1.2% sodium hyaluronate) viscoelastic solution
Features 
  • Excellent protection during high flow rate proedures
  • Proven chamber maintenance
  • Predictable staying power during high shear rate phaco conditions
  • Provides strong barrier of protection for corneal endothelium compared to high molecular weight viscoelastics
  • Description CoEase is designed to provide excellent protection and ease of use. It has the unique advantage of being closer to an adhesive in molecular weight than other cohesives. This allows CoEase to maintain viscosity at high shear rates, giving you the best of both worlds for superb performance during capsulorhexis, phaco, IOL insertion, and aspiration.
    Info Advanced Medical Optics, Inc.
    Customer Service: (714) 247-8200

    Related medicine products :

    1. CoEase
    2. AMO Vitrax (sodium hyaluronate) viscoelastic solution
    3. Boston Simplus Multi-Action solution
    4. Model 430 Visible Spectrophotometer High Resolution
    5. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
    6. High Resolution Minioptic Endoscope
    7. High Resolution Minioptic Laparoscopes
    8. Agarose 3:1 HRB™ - High Resolution Blend
    9. Agarose, high resolution, Molecular Biology Grade
    10. Agarose, ultra high resolution, Molecular Biology Grade
    11. Agarose, Fine Resolution
    Plastic micro-hematocrit capillary tubes from Globe Scientific Inc. are designed for use in 75 mm (3 inches) hematocrit centrifuges and come with many features....
    Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
    ... Vivid 3 system is designed to address ... performance, and offer an even wider range ... the OR. From color flow imaging with ... new Vivid 3 offers a wealth of ...
    ... Volcano's new VH IVUS technology ... allow simplified interpretation of ultrasound images ... composition of each patient's atherosclerotic plaques. ... plaque component types: fibrous, fibro-fatty, dense ...
    Medicine Products:
    (Date:5/2/2016)... and Shelton, CT (PRWEB) , ... May 02, 2016 , ... ... President and Owner of New England Low Vision and Blindness (NELV&B) , announces ... add more flexibility and convenience for people with vision impairments to get assessments, hands-on ...
    (Date:5/1/2016)... ... May 01, 2016 , ... ... that gives new mothers a better understanding of what to expect after they ... Adjusting to baby postpartum, · The blues and depression, · Breastfeeding beyond postpartum ...
    (Date:4/30/2016)... ... April 30, 2016 , ... Create ... Abstract users can distort and manipulate three-dimensional shapes with ease all within ... ranks, point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture ...
    (Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
    (Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
    Breaking Medicine News(10 mins):
    (Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
    (Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
    (Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
    Breaking Medicine Technology: